We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALEX
1926
DELISTED
Alexander & Baldwin
ALEX
| $981K | ﹤0.01% |
+59,567
| New | +$1.02M |
|
1927
UNIFI
UFI
$134M
| $980K | ﹤0.01% |
163,574
+9,760
| +6% | +$59.1K |
|
1928
Northeast Bank
NBN
$1.14B
| $979K | ﹤0.01% |
17,688
+5,237
| +42% | +$280K |
|
1929
Rambus
RMBS
$11B
| $979K | ﹤0.01% |
15,833
-8,067
| -34% | -$511K |
|
1930
Camden National
CAC
$976M
| $978K | ﹤0.01% |
29,167
+4,602
| +19% | +$156K |
|
|
ODP
1931
DELISTED
ODP
ODP
| $977K | ﹤0.01% |
18,418
+3,159
| +21% | +$165K |
|
|
MRSN
1932
DELISTED
Mersana Therapeutics
MRSN
| $976K | ﹤0.01% |
8,718
+1,864
| +27% | +$185K |
|
1933
Lifestance Health
LFST
$4.14B
| $975K | ﹤0.01% |
158,090
+87,819
| +125% | +$591K |
|
1934
Walker & Dunlop
WD
$1.53B
| $972K | ﹤0.01% |
9,614
+3,667
| +62% | +$352K |
|
1935
InvenTrust Properties
IVT
$2.59B
| $972K | ﹤0.01% |
+37,787
| New | +$952K |
|
1936
PJT Partners
PJT
$4.38B
| $967K | ﹤0.01% |
10,260
-30,270
| -75% | -$2.97M |
|
|
TBCH
1937
Turtle Beach Corp
TBCH
$277M
| $964K | ﹤0.01% |
+55,941
| New | +$676K |
|
1938
Plexus
PLXS
$7.23B
| $961K | ﹤0.01% |
+10,140
| New | +$976K |
|
|
ASRT
1939
DELISTED
Assertio
ASRT
| $961K | ﹤0.01% |
66,752
-17,330
| -21% | -$236K |
|
|
MAG
1940
DELISTED
MAG Silver
MAG
| $960K | ﹤0.01% |
+90,781
| New | +$832K |
|
|
LTC
1941
LTC Properties
LTC
$2.15B
| $958K | ﹤0.01% |
29,457
-113,794
| -79% | -$3.63M |
|
|
ENV
1942
DELISTED
ENVESTNET, INC.
ENV
| $956K | ﹤0.01% |
16,506
-96,394
| -85% | -$5.03M |
|
1943
Lyell Immunopharma
LYEL
$360M
| $956K | ﹤0.01% |
21,430
+9,356
| +77% | +$401K |
|
1944
Celcuity
CELC
$4.52B
| $955K | ﹤0.01% |
+44,221
| New | +$706K |
|
1945
Gossamer Bio
GOSS
$87M
| $954K | ﹤0.01% |
808,771
-213,490
| -21% | -$235K |
|
|
BNT
1946
Brookfield Wealth Solutions
BNT
$12.2B
| $954K | ﹤0.01% |
34,260
-9,150
| -21% | -$246K |
|
1947
Arrowhead Research
ARWR
$12.4B
| $952K | ﹤0.01% |
33,302
+7,400
| +29% | +$237K |
|
1948
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
| $951K | ﹤0.01% |
18,100
-15,200
| -46% | -$750K |
|
1949
Cogent Biosciences
COGT
$7.24B
| $946K | ﹤0.01% |
+140,710
| New | +$870K |
|
|
VRNT
1950
DELISTED
Verint Systems
VRNT
| $941K | ﹤0.01% |
28,379
-36,797
| -56% | -$1.1M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.